Congenital myopathy-1B caused by a homozygous RYR1 variant: A case report

Abstract

Congenital myopathies are a group of clinically and genetically diverse neuromuscular diseases that often present with stable and/or slowly progressive trunk and proximal weakness. Genetic analysis can help diagnose each congenital myopathy more accurately. Although an increasing number of other causative genes have been reported, ryanodine receptor 1 (RYR1)-related myopathy is the most common cause. Herein, we report the clinical presentation of a patient with congenital myopathy-1B (multiminicore disease) that was caused by a c.115 G>A homozygous variant of RYR1. The patient had normal cognitive abilities but was developmentally delayed and unable to walk. Electromyography revealed myogenic changes. The c.115G>A variant located in the second exon of RYR1 was found to be homozygous in the congenital neuromuscular gene panel. The patient’s parents and sister both carried the heterozygous variant. Clinical differences between family members with the homozygous and heterozygous variants of RYR1 highlight the correlation between the genotype and phenotype.

Keywords

Congenital myopathy-1B / Ryanodine receptor 1-related variants / Multiminicore disease

Funding

None.

Conflict of interest

The authors declare that they have no competing interests.

References

[1] Topaloglu H. Core myopathies-a short review. Acta Myol. 2020; 39(4):266-273. doi: 10.36185/2532-1900-029

[2] Shuaib A, Paasuke RT, Brownell KW. Central core disease. Clinical features in 13 patients. Medicine (Baltimore). 1987;66:389-396.

[3] D’Arcy CE, Bjorksten A, Yiu EM, et al. King-Denborough syndrome caused by a novel mutation in the ryanodine receptor gene. Neurology. 2008; 71:776-777. doi: 10.1212/01.wnl.0000324929.33780.2f

[4] Manning BM, Quane KA, Ording H, et al. Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: Genotype-phenotype correlation. Am J Hum Genet. 1998;62:599-609. doi: 10.1086/301748

[5] Ferreiro A, Monnier N, Romero NB, et al. A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene. Ann Neurol. 2002; 51:750-759. doi: 10.1002/ana.10231

[6] MacKenzie AE, Korneluk RG, Zorzato F, et al.The human ryanodine receptor gene: Its mapping to 19q13.1, placement in a chromosome 19 linkage group, and exclusion as the gene causing myotonic dystrophy. Am J Hum Genet. 1990; 46(6):1082-1089.

[7] Klein A, Lillis S, Munteanu I, et al. Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies. Hum Mutat. 2012; 33(6):981-988. doi: 10.1002/humu.22056

[8] Ogasawara M, Nishino I. A review of core myopathy: Central core disease, multiminicore disease, dusty core disease, and core-rod myopathy. Neuromuscul Disord. 2021; 31(10):968-977. doi: 10.1016/j.nmd.2021.08.015

[9] Cheng H, Lederer WJ, Cannell MB. Calcium sparks: Elementary events underlying excitation-contraction coupling in heart muscle. Science. 1993; 262:740-744. doi: 10.1126/science.8235594

[10] Gehlert S, Bloch W, Suhr F. Ca2+-dependent regulations and signaling in skeletal muscle: From electro-mechanical coupling to adaptation. Int J Mol Sci. 2015; 16(1):1066-1095. doi: 10.3390/ijms16011066

[11] Bronner F. Extracellular and intracellular regulation of calcium homeostasis. ScientificWorldJournal. 2001; 1:919-925. doi: 10.1100/tsw.2001.489

[12] Wilmshurst JM, Lillis S, Zhou H, et al. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann. Neurol. 2010; 68:717-726. doi: 10.1002/ana.22119

[13] Parker R, Schiemann AH, Langton E, et al. Functional characterization of C-terminal ryanodine receptor 1 variants associated with central core disease or malignant hyperthermia. J Neuromuscul Dis. 2017; 4(2):147-158. doi: 10.3233/JND-170210

[14] Monnier N, Procaccio V, Stieglitz P, Lunardi J. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha-1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet. 1997;60:1316-1325. doi: 10.1086/515454

[15] Avila G, O’Connell KM, Dirksen RT. The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease. J Gen Physiol. 2003; 121(4):277-286. doi: 10.1085/jgp.200308791

[16] Murayama T, Kurebayashi N, Ogawa H, et al. Genotype-phenotype correlations of malignant hyperthermia and central core disease mutations in the central region of the RYR1 channel. Hum Mutat. 2016; 37(11):1231-1241. doi: 10.1002/humu.23072

[17] Murayama T, Kurebayashi N, Yamazawa T, et al. Divergent activity profiles of type 1 ryanodinereceptor channels carrying malignant hyperthermia and central coredisease mutations in the amino-terminal region. PLoS One. 2015; 10(6):e0130606. doi: 10.1371/journal.pone.0130606

[18] Harikrishna GV, Padmanabha H, Polavarapu K, et al. Phenotype-genotype correlation of a cohort of patients with congenital myopathy: A single centre experience from India. J Neuromuscul Dis. 2024; 11(5):935-957. doi: 10.3233/JND-230021

[19] Elbaz M, Ruiz A, Bachmann C, et al. Quantitative RYR1 reduction and loss of calcium sensitivity of RYR1Q1970fsX16+A4329D cause cores and loss of muscle strength. Hum Mol Genet. 2019; 28(18):2987-2999. doi: 10.1093/hmg/ddz092